Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide-dismutase: II. Induction of specific CD8+ cytotoxic lymphocytes and sensitized CD4+ IFN-γ-producing cell

Microbiology and Immunology

Volumn 50, Issue 5, 2006, Pages 389-393

  Andrews, Edilia ^a   Salgado, Paulina ^a   Folch, Hugo ^b   Oñate, Angel ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

Author keywords

Brucella abortus; Cu Zn superoxide dismutase; Cytotoxicity; Vaccine

Indexed keywords

BACTERIAL VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; LIVE VACCINE; MANGANESE SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRUCELLA ABORTUS; BRUCELLOSIS; CYTOTOXIC LYMPHOCYTE; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; IMMUNITY; MOUSE; NONHUMAN;

ANIMALIA; BACTERIA (MICROORGANISMS); BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; ESCHERICHIA COLI;

EID: 33646855243     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03805.x     Document Type: Article

References (15)

1. Corbel, M.J. 1997. Brucellosis: an overview. Emerg. Infect. Diseases 3: 213-221.
2. He, J., Vemulapalli, R., Zeytun, A., and Schurig, G.G. 2001. Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51. Infect. Immun. 69: 5502-5508.
3. Ko, J., and Splitter, G. 2003. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 16: 65-78.
4. Montaña, N.I., Rueda, O.E., Calderón, C.P., Ortega, A., Puentes, A.R., Gallego, M.I., and Mariño, O.C. 1998. Medición de respuesta inmune humoral y celular frente a antigénos de Brucella abortus RB51 en bovinos. Arch. Med. Vet. 30: 109-123.
5. Moriyón, I., Grilló, M.J., Monreal, D., González, D., Marín, C., López-Goñi, I., Mainar-Jaime, R.C., Moreno, E., and Blasco, J.M. 2004. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet. Res. 35:1-38.
6. + T cells. Infect. Immun. 72: 2081-2087.
7. Rblo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I and class II deficient mice. Eur. J. Immunol. 25: 2551-2559.
8. Oñate, A., Céspedes, S., Cabrera, A., Rivers, R., González, R., Folch, H., Muñoz, C., and Andrews, E. 2003. A DNA vaccine encoding Cu, Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice. Infect. Immun. 71: 4857-4861.
9. Oñate, A., Vemulapalli, R., Andrews, E., Schurig, G., Boyle, S., and Folch, H. 1999. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect. Immun. 67: 986-988.
10. Schurig, G., Roop, R., Bagchi, T., Boyle, S., Buhrman, D., and Sriranganathan, N. 1991. Biological properties of RB51, a stable rough strain of Brucella abortus. Vet. Microbiol. 28: 171-188.
11. Snedecor, G.W., and Cochran, W.G. 1989. Statistical methods, Iowa State University, Ames, U.S.A.
12. Splitter, M.G., Oliveira, S., Carey, M., Miller, C., Ko, J., and Covert, J. 1996. T lymphocyte mediated protection against facultative intracellular bacteria. Vet. Immun. Immunopathol. 54: 309-319.
13. Stevens, M., Ilennager, S.G., Olsen, S.C., and Cheville, N.F. 1994. Serological response in diagnostic test for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51. J. Clin. Microbiol. 32: 1065-1066.
14. Tabatabai, L.B., and Pugh, G.W. 1994. Modulation of immune responses in BALB/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine. Vaccine 12: 919-924.
15. Young, E.J. 1997. Especies de Brucella, p. 2300-2307. In Mandel, G., Bennett, J., and Dolin, R. (eds), Enfermedades Infecciosas, Principle y Práctica, Editorial Medica Paramericana S.A., Madrid.